TY - JOUR
T1 - Models of care and associated targeted implementation strategies for cancer survivorship support in Europe
T2 - a scoping review protocol
AU - Prue, Gillian
AU - Czamanski-Cohen, Johanna
AU - Kassianos, Angelos P
AU - Pilleron, Sophie
AU - Ladas, Aristea
AU - Akcakaya Can, Aysun
AU - Roldán-Jiménez, Cristina
AU - Degi, Csaba Laszlo
AU - Işcan, Gökçe
AU - Arslan, Sevban
AU - de Boer, Angela G E M
AU - Celebic, Aleksandar
AU - Doñate-Martínez, Ascensión
AU - Alhambra-Borrás, Tamara
AU - Mitrevski, Boce
AU - Marzorati, Chiara
AU - Pravettoni, Gabriella
AU - Grasso, Roberto
AU - Nazik, Evsen
AU - Pawlowska, Ewa
AU - Mucalo, Iva
AU - Browne, John Patrick
AU - Tripkovic, Katica
AU - Vojvodic, Katarina
AU - Karekla, Maria
AU - Moschofidou, Maria
AU - Bayram, Sule Biyik
AU - Brandão, Tânia
AU - Arndt, Volker
AU - Jaswal, Poonam
AU - Semerci, Remziye
AU - Bozkul, Gamze
AU - Sahin, Eda
AU - Toygar, Ismail
AU - Frountzas, Maximos
AU - Martins, Rui Miguel
AU - Jefford, Michael
AU - Keane, Danielle
AU - Hegarty, Josephine
N1 - Funding
This work has been completed as part of a European Cooperation in
Science and Technology (COST Association) project titled: CA21152 Implementation
Network Europe for Cancer Survivorship Care (INE-CSC). The views expressed in
this paper are of the authors of the paper and not the EU Commission.
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
PY - 2025/2/16
Y1 - 2025/2/16
N2 - INTRODUCTION: Cancer and its treatments can lead to a wide range of side-effects that can persist long after treatments have ended. Across Europe, survivorship care is traditionally hospital-based specialist-led follow-up, leading to gaps in supportive care. Improved screening, diagnosis and treatment increase survival rates. With more individuals living with, through and beyond cancer, the predominance of the hospital-based specialist model is unsustainable, costly and resource-intensive. An understanding of what alternative Models of Care are available and the barriers and facilitators to their implementation is a first step towards enhancing supportive care across the cancer journey. The aim of this scoping review is to source and synthesise information from studies evaluating patient-oriented models of cancer survivorship supportive care for adults in Europe.METHODS AND ANALYSIS: The scoping review will be reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses-Scoping Review Extension guidelines and will be guided by a six-stage methodological framework. A search strategy has been developed according to the Population, Concept and Context structure and will be applied to seven databases. A targeted search of grey literature will be completed. All identified records will be screened using predefined eligibility criteria by at least two researchers and undergo full-text review for inclusion. Data pertaining to the conceptualisation, evaluation and implementation of sourced Models of Care will be extracted.ETHICS AND DISSEMINATION: As there is no primary data, ethical approval is not required. This review will be conducted as part of the EU COST Action CA21152-Implementation Network Europe for Cancer Survivorship Care. The protocol and subsequent scoping review will be published in a peer-reviewed journal. The Action involves representatives from most countries across Europe which will assist with the dissemination of the work to key stakeholders.
AB - INTRODUCTION: Cancer and its treatments can lead to a wide range of side-effects that can persist long after treatments have ended. Across Europe, survivorship care is traditionally hospital-based specialist-led follow-up, leading to gaps in supportive care. Improved screening, diagnosis and treatment increase survival rates. With more individuals living with, through and beyond cancer, the predominance of the hospital-based specialist model is unsustainable, costly and resource-intensive. An understanding of what alternative Models of Care are available and the barriers and facilitators to their implementation is a first step towards enhancing supportive care across the cancer journey. The aim of this scoping review is to source and synthesise information from studies evaluating patient-oriented models of cancer survivorship supportive care for adults in Europe.METHODS AND ANALYSIS: The scoping review will be reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses-Scoping Review Extension guidelines and will be guided by a six-stage methodological framework. A search strategy has been developed according to the Population, Concept and Context structure and will be applied to seven databases. A targeted search of grey literature will be completed. All identified records will be screened using predefined eligibility criteria by at least two researchers and undergo full-text review for inclusion. Data pertaining to the conceptualisation, evaluation and implementation of sourced Models of Care will be extracted.ETHICS AND DISSEMINATION: As there is no primary data, ethical approval is not required. This review will be conducted as part of the EU COST Action CA21152-Implementation Network Europe for Cancer Survivorship Care. The protocol and subsequent scoping review will be published in a peer-reviewed journal. The Action involves representatives from most countries across Europe which will assist with the dissemination of the work to key stakeholders.
KW - Humans
KW - Europe
KW - Cancer Survivors
KW - Neoplasms/therapy
KW - Research Design
KW - Survivorship
UR - https://pubmed.ncbi.nlm.nih.gov/39956597/
U2 - 10.1136/bmjopen-2024-085456
DO - 10.1136/bmjopen-2024-085456
M3 - Review article
C2 - 39956597
SN - 2044-6055
VL - 15
JO - BMJ Open
JF - BMJ Open
IS - 2
M1 - e085456
ER -